Ruti Aga's Six-Year Ban: A Forged Prescription Killed the Defence Real Records Could Have Saved

In March, at a half marathon in China, Ruti Aga finished first. The Athletics Integrity Unit's statement came on Thursday: six years, a forged prescription, a family member described as a doctor. The statement does not contain the time she ran. The race that generated this entire case has no number attached to it in the release. I keep forty years of filing in one folder, and it is full of results like that — names, dates, no numbers. Eleven seconds of silence taught me more than any question I ever asked. In Bangkok in 2026, after Jyotirmoyee Sikdar's second gold, I deliberately let eleven seconds of stadium noise run before I raised the mic. Here it is inverted: the statement is making the noise, and the voice is missing. Aga is 32. She belongs to the Ethiopian women's marathon cohort that kept standing on Major podiums and never converted a global championship medal. Second in Berlin 2026 in 2:18:34, champion at the 2026 Tokyo Marathon in 2:20:40, three runner-up finishes at World Marathon Majors. That is a genuine elite marathon record, not a paper one. Part of it survives — everything before that March race in China. The sanction is anchored to that race, so earlier results are not automatically annulled. The statement does not say what will be. Until it does, nobody should treat the 2026 Tokyo title as erased. This is where the real subject of the case sits. In the Athens mixed zone in August 2026 I asked a team physio why Anju Bobby George was training at half the volume of her rivals. The answer was one kidney, present from birth. The number was 6.83. The story was a kidney nobody mentioned. From that day I began a private ledger — every athlete's employer, monthly salary, funding source, medical history — and wrote myself one rule: no result without the conditions that produced it. Ruti Aga's case has to be read in that ledger's language, because the substance here is not the primary subject. Medical governance is. The arithmetic is plain. Two years for the presence violation. Four years for fabricating the prescription and for misleading statements during the investigation. Six years in total, counted from the provisional suspension — that is, from 10 September. The sum tells us the panel refused the no-significant-fault mitigation that would have cut the presence sanction. Backdating to 10 September is not a concession; provisional suspension time merges into the ban rather than sitting alongside it. Technically, the sanction is standard rather than exceptional. What is exceptional is its cause. And here the reporting made a basic error. Methylprednisolone was called a "prohibited steroid" and described as classed performance-enhancing by WADA. That is incomplete. It is a glucocorticoid, WADA Prohibited List class S9, not an anabolic steroid under S1. S9 substances are prohibited in-competition only — by injection, oral or rectal routes. A therapeutic knee injection given out-of-competition is entirely legal; it becomes a violation only if residues are present in a sample taken in-competition. On the road, the testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught. Aga therefore had a legitimate legal pathway — clean documentation of timing, route and medical necessity. The word "steroid" makes that pathway invisible, which is why this is not merely a vocabulary slip. Now look at the chain that closed that pathway. The prescription was traced to a clinic that did not exist. The person who issued it was a family member with no medical registration. He claimed to have used an old prescription pad from a former workplace, and the clinic itself explicitly disowned the pad. Three independent verifications, three failures. That is not a filing error; it is the signature of an athlete operating without a credentialed team physician — no TUE, no route-specific washout calculation, no doctor whose name could survive a document check. And here I think of my own country. The six women hit with CAS-confirmed bans in 2026 included members of the 4x400 relay squads I had celebrated on air from Delhi's Jawaharlal Nehru Stadium in October 2026. That was never a story about consumption; it was a story about the supplement supply chain. Nobody was telling those girls what they were swallowing, who was testing them, who was signing off. I wrote a mandatory asterisk paragraph into every medal segment after that. It cost me two sponsors and one anchor chair. Looking at that Chinese half marathon in March, the same vacancy appears inside Ethiopian road running — cheap treatment is available, recognised medical support is not. The counter-intuitive conclusion here does not come from the accusations. It comes from the system. The AIU's enforcement frontier has shifted from detection to document verification. The first question used to be whether the substance was found; now it is whether the paper is real. Masking a knee injury with a glucocorticoid is ordinary practice among marathoners, because racing hurt is necessary in an appearance-fee economy. A six-year ban for a substance with no proven endurance benefit will be cited as evidence of rigorous monitoring — and also as evidence that rigour lands hardest on athletes without a lawyer or a team doctor. Both statements are true at once, which is why the lazy corrupt-official caricature should be avoided. The real antagonist is the calendar: Asia's label races combine large appearance-fee budgets, deep East African elite fields, and the same races are the AIU's highest-yield testing ground. The earning economy and the testing economy are colliding on one course. A six-year ban at 32 means she returns at 38. In Ethiopian women's marathons, even a 2:18 performer is not automatically selectable — the sub-2:16 group is standing right there. The sanction is, in practice, career-terminal. What she keeps is the 2026 Tokyo title and three Major podiums: the record of a real marathoner, which no prescription can create or erase. Everything else is now the case of a race with no number. If anything needs learning from this, it is that the next essential item for a rising woman road runner is not a faster shoe. It is a team doctor whose name, registration number and phone can be handed to an investigator the same day. Eleven seconds of silence tell you what happened in a race; a ledger tells you what was absent behind it.